Volume 19, Number 11—November 2013
Full Genome of Influenza A (H7N9) Virus Derived by Direct Sequencing without Culture
Highlight and copy the desired format.
|EID||Ren X, Yang F, Hu Y, Zhang T, Liu L, Dong J, et al. Full Genome of Influenza A (H7N9) Virus Derived by Direct Sequencing without Culture. Emerg Infect Dis. 2013;19(11):1881-1884. https://dx.doi.org/10.3201/eid1911.130664|
|AMA||Ren X, Yang F, Hu Y, et al. Full Genome of Influenza A (H7N9) Virus Derived by Direct Sequencing without Culture. Emerging Infectious Diseases. 2013;19(11):1881-1884. doi:10.3201/eid1911.130664.|
|APA||Ren, X., Yang, F., Hu, Y., Zhang, T., Liu, L., Dong, J....Jin, Q. (2013). Full Genome of Influenza A (H7N9) Virus Derived by Direct Sequencing without Culture. Emerging Infectious Diseases, 19(11), 1881-1884. https://dx.doi.org/10.3201/eid1911.130664.|
An epidemic caused by influenza A (H7N9) virus was recently reported in China. Deep sequencing revealed the full genome of the virus obtained directly from a patient’s sputum without virus culture. The full genome showed substantial sequence heterogeneity and large differences compared with that from embryonated chicken eggs.
Recently, a novel influenza A (H7N9) virus infected humans in China (1,2), leading to great concerns about its threat to public health (3). However, almost all the current genomes of the novel subtype H7N9 virus have been sequenced after culture in embryonated chicken eggs or mammalian cells. Switching the evolutionary selection pressure from in vivo human respiratory tract to embryonated chicken eggs might introduce mutations into the final genome sequences during culture (4). We report determination of the full genome of the influenza A (H7N9) virus derived directly by deep sequencing, without virus culture, from a sputum specimen of an infected human. Deep sequencing provides a direct way to evaluate the genome characteristics and potential virulence and transmissibility of the novel influenza A (H7N9) virus.
We collected a sputum specimen from a 54-year-old woman with fever, cough, sputum production, and pneumonia. Influenza A (H7N9) virus was detected in the specimen by specific real-time reverse transcription PCR (RT-PCR). The specimen was then processed with a viral particle–protected nucleic acid purification method (5). Total RNA was extracted and amplified by sequence-independent PCR (5) and then sequenced with an Illumina/Solexa GAII sequencer (Illumina, San Diego, CA, USA). Reads generated by the Illumina/Solexa GAII with lengths of 80 bases were directly aligned to those nucleotide sequences of influenza A viruses in the National Center for Biotechnology Information nonredundant nucleotide database by the blastn program in the BLAST (6) software package, version 2.2.22 (www.ncbi.nlm.nih.gov/blast) with parameters −e 1e−5 −F T (−e 1e−5 for selection of highly similar reads and −F T for masking the low-complexity reads) after filtering of the sequence adapters and RT-PCR primers. No assembly was performed before alignment. We obtained 19,177 reads aligned to influenza A viruses.
We then conducted a reference-guided assembly based on the 19,177 reads by the Seqman program in the DNAStar software package version 7.1 (http://www.dnastar.com). The novel influenza A (H7N9) virus A/Anhui/1/2013was selected as the reference. With 80% minimum sequence similarity tolerance and 12 bp minimum match size, those 19,177 reads were assembled into 439 contigs. The top 8 contigs covered by the most reads corresponded to the 8 genome segments of the novel influenza A (H7N9) virus. The other contigs did not align to the reference virus, which might have resulted from sequencing or assembling errors. Calculating the consensus sequence, we obtained the genome of the influenza A (H7N9) virus directly from the sputum specimen of this patient. Further RT-PCR and Sanger sequencing confirmed the quality of the assembled subtype H7N9virus genome. Sequences were deposited in GenBank under accession nos. KF226105–KF226120 and KF278742–KF278749.
The influenza A (H7N9) genome that we report varies from that obtained by Sanger sequencing after passage in the allantoic sac and amniotic cavity of 9–11-day-old specific pathogen–free embryonated chicken eggs for 48–72 hours at 35°C (Table 1). In the nucleocapsid protein (NP) segment, 15 point mutations were found; 13 were synonymous and 2 induced amino acid changes S321N and M371I. In the nonstructural (NS) protein segment, 5 point mutations were found; all caused amino acid changes R59H, P107L, and V111Q. In the polymerase acidic (PA) protein segment, 3 point mutations were found, 1 of which caused amino acid change V707F. In the polymerase basic 1 (PB1) protein segment, 2 point mutations were found, both of which were synonymous. In the PB2 segment, 2 point mutations were found, 1 of which caused amino acid change S534F.
The influenza A (H7N9) genome also demonstrates significant intraspecimen heterogeneity. Deep sequencing revealed that the average coverage (ratio of the total number of nucleotides of all reads to the length of the reference gene) of the 8 genes was quite inhomogeneous. Average coverage (± SD) was highest for neuraminidase (NA) (131.94 ± 30.25) and second highest for NP (130.41± 27.01). The average coverages of PB2, PB1, PA, matrix protein, and hemagglutinin were 99.89 (± 22.49), 95.35 (± 21.34), 43.35 (± 14.13), 53.73 (± 17.67), and 69.82 (± 19.02), respectively. Average coverage was lowest for NS (27.73± 11.31).
Besides the gene abundance, the genome sequence of influenza A (H7N9) virus also demonstrated heterogeneity (the heterozygous peak threshold 80%). In total, 22 positions were confirmed by PCR and Sanger sequencing to be heterogeneous (Table 2). In the NP segment, 4 positions demonstrated heterogeneity; 3 were synonymous and 1 induced amino acid change E421K. In the NS segment, 3 positions demonstrated heterogeneity; 2 were synonymous and 1 induced amino acid change R140W. In the hemagglutinin segment, 7 positions demonstrated heterogeneity; 6 were synonymous and 1 induced amino acid change H242Y. In NA, 3 positions demonstrated heterogeneity; 2 induced amino acid changes (S92L and S108L) and 1 was synonymous. In the PA segment, 2 positions demonstrated heterogeneity; both were synonymous. In the PB2 segment, 3 positions demonstrated heterogeneity; all were nonsynonymous (S532L, S533L, and S534F). All these heterogeneous sites were confirmed by PCR and Sanger sequencing; only 1 site overlapped with the mutation sites after passage in embryonated chicken eggs.
Compared with the reference influenza A (H7N9) virus strain A/Anhui/1/2013, the influenza A (H7N9) virus demonstrated prominent sequence differences (Table 2). In particular, the amino acid at the 627 position of PB2 of A/Anhui/1/2013 is K, whereas the corresponding amino acid in the subtype H7N9 genome is E. The amino acid at the 368 position of PB1 of A/Anhui/1/2013 is V, whereas the corresponding amino acid in the subtype H7N9 genome is I. The E627K mutation in PB2 and the I368V mutation in PB1 are closely associated with the virulence and transmissibility of avian influenza A virus in mammals (1). E627K in PB2 was observed in A/Shanghai/1/2013, A/Shanghai/2/2013, and A/Anhui/1/2013 viruses (1). A/Zhejiang/DTID-ZJU01/2013 virus does not have this mutation but has a complementary mutation D701N in PB2 (2). I368V in PB1 was observed in A/Shanghai/2/2013 and A/Anhui/1/2013 viruses, but A/Shanghai/1/2013 virus does not have this mutation (1).
MEGA5.0 (www.megasoftware.net) was used to construct the phylogenetic trees on the basis of the nucleotide sequences of all influenza A (H7N9) viruses in the Global Initiative on Sharing All Influenza Data (GISAID) database (7). We conducted 2 rounds of phylogenetic analysis. First, to examine whether this subtype H7N9 virus is clustered with the available subtype H7N9 strains, we included all influenza A (H7N9) viruses in the GISAID database. To construct the multiple sequence alignment, we used the MUSCLE package with default parameters (www.megasoftware.net/); then, to construct the phylogenetic trees with 1,000 bootstrap replicates, we used the minimum-evolution method. Results suggested that all 8 genome segments are closely related to the available influenza A (H7N9) virus strains.
We next included all influenza A (H7N9) viruses isolated in China in 2013 to closely investigate the relationships between this virus and available subtype H7N9 genomes isolated during epidemics. However, the phylogenetic topologies based on different gene segments were not consistent (Figures 1, 2; Technical Appendix Figures 1–6 [PDF - 565 KB - 6 pages]), suggesting that the influenza A (H7N9) virus may have persistently evolved for a while (8).
Using deep sequencing technologies, we derived the full-length genome of the novel influenza A (H7N9) virus directly from the sputum specimen of a patient, without conducting virus culture. The full genome revealed substantial sequence heterogeneity within the specimen, obvious sequence variations from that obtained from embryonated chicken eggs, and prominent differences from the available influenza A (H7N9) strains, most of which were sequenced after culture.
Dr Ren is an assistant professor at the Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College. His research focuses on the bioinformatics and computational biological questions of pathogens.
We acknowledge those who contributed to the generation of the genome sequences of influenza A (H7N9) viruses in GISAID, on which this research is based.
This work was supported by the National S&T Major Project, “China Mega-Project for Infectious Disease” (grant No. 2013ZX10004101).
- Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888–9.
- Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013;381:1916–25.
- Uyeki TM, Cox NJ. Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med. 2013;368:1862–4.
- de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667–72.
- Wu Z, Ren X, Yang L, Hu Y, Yang J, He G, Virome analysis for identification of novel mammalian viruses in bat species from Chinese provinces. J Virol. 2012;86:10999–1012.
- Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–402.
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.
- Koopmans M, de Jong MD. Avian influenza A H7N9 in Zhejiang, China. Lancet. 2013;381:1882–3.
- Figure 1. . . Phylogenetic tree of the influenza A (H7N9) viruses isolated in China in 2013, based on the hemagglutinin gene segment. Scale bar indicates nucleotide differences per unit length....
- Figure 2. . . Phylogenetic tree of the influenza A (H7N9) viruses isolated in China in 2013, based on the neuraminidase gene segment. Scale bar indicates nucleotide differences per unit length....
- Table 1. Mutations of directly sequenced influenza A (H7N9) virus and that obtained from chicken egg culture
- Table 2. Heterogeneous genomic positions of directly sequenced influenza A (H7N9) virus and its protein differences from other viruses
Technical AppendixCite This Article
1These authors contributed equally to this article.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Qi Jin, No. 6 St Rongjing East, BDA, Beijing, 100176, People’s Republic of China
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: August 15, 2013
- Page last updated: October 29, 2013
- Page last reviewed: October 29, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)